BGI Genomics Co Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BGI Genomics Co Ltd with three other
miscellaneous service companies in Asia:
Hutchison China Meditech Limited
sales of 1.62 billion Chinese Renmimbi [US$235.03 million]
of which 69%
was Is Operating - Prescription Drugs PRC),
Chabiotech Co Ltd
of South Korea
(418.88 billion Korean Won [US$372.81 million]
Takara Bio Inc
based in Japan
(29.38 billion Japanese Yen [US$261.73 million]
of which 90%
was Bio support).